FGF1 and type 2 diabetes mellitus: Recent studies reveal that a single intracerebroventricular (i.c.v) injection of FGF1, at a dose that is ineffective when administered systemically, normalizes hyperglycemia in different rodent models of T2D [48, 49, 51, 52].